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1. Introduction  
The study and use of biomaterials dates back to very ancient cultures such as that of the 
Mayas, the Egyptians and the Phoenicians; however the study on biomaterials as a science is 
to be considered recently developed, indeed dating back only to half of the nineteenth 
century. Archeological finds showed that Phoenicians used to tie artificial teeth to the 
natural ones with golden wires and that the Egyptians used different materials to build 
prosthesis. The first find that reached us, dates back to the Egyptian era (1000 - 600 b.C.) and 
is a woman’s toe. The device named “Cairo Toe” is made of wood and skin, and is 
assembled in order to be flexible and both the shape and the wearing effect of time suggest 
that it helped its owner to walk; then it is considered the first functional prosthesis (Huebsch 
& Mooney, 2009). More finds instead, such as for hands and feet or a finger of parchment 
and chalk kept at the British Museum in London, are only aesthetic substitutes, since this 
culture used to carefully get ready for the afterlife. As far as regards oral implantology, the 
first find reached to us is a Maya’s era mandible’s splinter with three implants made of half 
shell which were the substitute of three missing foreteeth, datable approximately to VIII 
Century a.C., discovered by the archeologist Wilson Popenoe, in 1931, during some diggings 
in  Playa de los Muertos, in Honduras. According to some studies made by the Brasilian, but 
native of Italy, dentistry Amedeo Bobbio during 1970, the three shells were not implanted in 
the relative alveolus after death, but during the life. Indeed, by the find’s X-Ray, he noticed a 
real, “osteointegration”, as we woluld say today all around the shells, certainly due to their 
largecontent of calcium phosphate (Bucci Sabattini, 2007). 
This find represents a fundamental stage in biomaterials’ history being the first 
osteointegrated implant which came to us. Considering the recent history, since ‘800, there 
are several documentations of efforts and experiments for orthodontic implants. The 
greatest development of endosseous implantology has been in the ‘70s with Stefano 
Tramonte’s suggestion to use titanium to replace surgical steel as an implant’s material. The 
Dutch School, also around the half of ‘70s, introduced the use of calcium hydroxyapatite 
inspired by previous studies on tricalcium phosphate. The osteointegrated implant 
methodology was initaited in the ‘80s by doctor Per-Ingvar Branemark, professor in applied 
biotechnologies at University of Gothenburg, who developed the osteointegrated implants 
in the oral surgery, providing inspiration for other applications. Branemark defined 
osteointegration as the direct structural and functional connection between living bone and 
the surface of a load bearing artificial implant (Brånemark et al., 1977). The basic 
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requirement to establish real and lasting tissue integration to biomaterials, is based on 
detailed understanding of hard and soft host’s tissues response, the surgical preparation and 
implantation of the device (Albrektsson et al., 1981). This definition represents the big 
novelty in implantology during ‘80s, in fact, is no doubt that to guarantee a lasting bone 
healing there has to be a direct contact between bone and the alloplastic material. All recent 
literature shows, unmistakably, that the implant, using the “osteointegrated” methodology, 
is a reliable, valid and predictable solution. 
2. Titanium: from bioinert material to bioactive material  
The modern biomaterials’ science since the ‘80s has been characterized by a growing 
emphasis on the identification of specific parameters which are critical to their performance. 
The union of biomaterials’ science with new emerging insight from biology studies, as cell-
matrix interaction, cell signaling processes, (Albrektsson & Wennerberg, 2005), creates a 
multidisciplinary approach to biomaterial’s science. Because there are several different 
approaches that can be used to study a biomaterial, also its classifications are numerous. 
Considering the effects of biological environment on the implanted material, a biomaterial 
can be defined as biostable or biodegradable. Materials able to resist to the change action by 
the biological environment, with which they are in contact, can be classified as bio-stable; 
unlike materials that undergo a gradual demolition and a chemical transformation, as result 
of specific actions made by the host that are classified as biodegradable. 
On the other hand, considering the interaction between biomaterial and body, they can be 
classified as: 
- bioinert, material that once inserted into the host does not undergo any modification, 
and does not encourage any kind of specific response in the surrounding tissue; 
- bioactive, materials that induce a specific response of the host tissue in the peri-implant 
region, due to interactions between the molecules at tissue-implant interface; 
- bioabsorbable, those materials that promote a regenerative response in the host tissue, 
and are gradually absorbed and replaced by newly formed tissue (Park & Lakes, 1979). 
In the specific case of endosseous biomaterials, the implant’s effect on the new-deposition 
can be defined as osteoinductive or osteoconductive. Osteoinduction is the ability of a 
biomaterial to induce bone’s new formation in heterotopic situation, which is when it is 
placed in a non-osteogenic tissue (Wilson-Hench, 1987). The osteoconduction is the capacity 
of a biomaterial to stimulate and to induce osteogenesis in a vital bone (Wilson-Hench, 
1987). Osteoinductive materials are mainly used to treat large bone defects or to regenerate 
bone where normally would not be a spontaneous regeneration, whereas osteoconductive 
materials are widely used as osteointegrated endosseous implants. In the matter of 
osteointegrated implanotlogy, both research and industry, were focused almost exclusively 
on the use of a bioinert material with intermediate proprieties: the titanium. It now 
represents a good compromise between mechanical and biological requirements. The 
titanium is considered the first choice for endosseous implants due to its specific proprieties: 
the high mechanical strength, the high corrosion resistance and the excellent 
biocompatibility. Titanium’s modulus of elasticity is just the half as compared to stainless 
steel so that it results a lower stiffness, with the same shape, which gives to the implant a 
greater adaptation skill to the bone’s elastic proprieties. This characteristic supports the 
growing interest on titanium as material for all applications that simultaneously require 
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high mechanical characteristics, low weight and high corrosion resistance. Titanium 
implants can be made from commercially pure titanium (Ti cp) or its alloys. The most used 
one is Ti-6Al-4V (Hanawa, 1999). Titanium is classified as bioinert; because of its ability to 
isolate oneself from the outside through a layer of oxide that is formed spontaneously by the 
contact with the biological environment. Various oxides such as TiO, TiO2 and TiO3 are 
present on the surface of titanium. TiO2 is the most stable so it is the most frequently 
encountered. Data shows the rapid formation of a titanium oxide layer of approximately 10 
Å in less than a thousandth of a second, that increases up in thickness to 50-100 Å in a 
minute (Macdonald et al., 1998). The layer of oxide is inert, extremely smooth, tenacious, 
adherent, and if, during the implantation, the layer was damaged, it will be immediately re-
established. The osteointegration protagonist is the titanium oxide, because its chemical 
stability prevents the surface corrosion and the spread of metal ions within tissues. These 
proprieties give a high degree of biocompatibility to titanium. In endosseous implants’field 
the aim of current researches is to create not only biocompatible, but also bioactive 
materials. It means that these materials can play an active role in stimulating or promote the 
bone apposition. In this way the implant is no longer considered as a simply bone’s 
functional support but it helps the host tissue to form new bone. The study of bioactive 
materials contains a wide number of new prospects and leads to the overcoming of previous 
concepts of biocompatibility. When a metal implant is surgically inserted, its outer surface 
comes into close contact with the host tissue, and this leads to various physical-chemical and 
biochemical interactions which involve macromolecules and tissue molecules from 
biological fluids (Macdonald et al., 1998). The literature describes that biological tissues 
interact with the surface of an implant (0.1-1 nm), so the surface pattern  plays a key role in 
the osteointegration. In order to improve implant osteointegration many treatments, to 
modify the surface characteristics, have been studied and applied (Anselme et al., 2000). The 
research is directed to develop treatments to improve the bone implant interface that make 
possible to consider titanium as a bioactive and not only as bioinert material. Three main 
approaches to surface modification are used: physical methods, chemical-electrochemical 
methods, and biochemical functionalization. Physical treatments are based on the idea that 
peculiar characteristics of the implant surface may facilitate osteointegration. Changes in 
both macro and micro architecture are designed to increase the surface contact area between 
implant and bone tissue; facilitating the deposition of calcium phosphate and improving 
bone implant’s mechanical stability in terms of tensile strength and torsion strength. The 
modifications of titanium surface topography lead to a better response of bone tissue, 
because the deposition of mineralized bone within the surface irregularities increases the 
bond between the bone and the implant (Cooper, 2000; Thomas & Cook, 1985;, Klokkevold 
et al., 2001). Among the physical methods of titanium surface modification, of particular 
interest are the sandblasting and the coating with titanium plasma spray (TPS). Chemical 
and electrochemical treatments are applied on a material when changes in the chemical 
composition of its surface are required. Within chemical treatments, both the acid etching 
and the surface coatings with calcium phosphate ceramics and in particular with the 
hydroxyapatite, are widely considered. The electrochemical treatments produce stable, 
porous and oxygen enriched coatings. The oxide layer created with such treatments, can be 
enriched with electrolytes dissolved in the medium during the deposition process (anode / 
cathode). The most recent developments in the treatments of bioactive titanium and alloys 
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are the biochemical ones, these can be considered as a method of surface modification based 
on the current knowledge about biological and biochemical cells functions and 
differentiation.  
2.1 Biomimetic implants  
The biomaterials of new generation are not only biocompatible but also bioactive, 
stimulating specific cellular responses and activating genes that stimulate living tissues. 
Today, the interest is focused on biomimetic treatments, developed to promote and 
accelerate bone apposition directly on the implant surface (Sun & Qing, 2011). The main 
idea, on which this recent approach is based, is the attempt to give to the material a specific 
biological activity that accelerate the healing process and that promote osteointegration. 
Biomimetic surfaces are obtained either through electro-chemical and biochemical 
treatments. The main goal of biomimetic treatment is the modification of the surface 
composition and morphology, in order to positively influence the response of biological 
tissue through an appropriate cell colonization. Nowadays, there are a lot of knowledges 
about the mechanisms of cells adhesion to substrates. Many progresses have been done in 
determining the role of molecules involved in the regulation of proliferation, cell 
differentiation and tissue remodeling. The development of these new knowledges made 
possible the design of a new generation of biomaterials that can promote and support the 
osteoblasts adhesion to the implant and consequently its osteointegration. 
2.1.1 Biomimicry to improve osteoblast adhesion  
Several extracellular matrix proteins are involved in the biochemical steps necessary for cells 
adhesion. For this reason, the molecules contained in the non fibrillar extracellular matrix 
component have been extensively studied. These studies allowed the isolation and 
identification of their role. Glycoproteins and glycolipids exposed on the outer surface of the 
cell membrane play very specific tasks, such as signals receiving and cell-cell recognition, 
act to promote cell adhesion during the tissue formation. The cell membrane on its surface 
has many different receptors, some of them are ubiquitarious, it means that they are almost 
in all cell types, while others are characteristics of different cell types. Different are also the 
selectivity and affinity of receptors. 
The use of biological factors to promote the adhesion of osteoblasts, such as BMPs, 
fibronectin and vitronectin, is not an optimal solution. It is influenced by a number of 
drawbacks: first of all because these proteins are complex molecules, often unstable and 
sometimes they are poorly soluble in a biological environment; their biological activity is 
influenced by the integrity of his tertiary structure (protein folding) and their use is limited 
by the cost of production. In addition we also have to consider the difficulty of controlling 
the local concentration at the interface implant-bone tissue where these molecules have to 
perform their biological activity (Bagno et al., 2003). To avoid these problems, the research 
has been directed to the identification of biologically active fragments; which come from 
adhesion factors or growth factors that can be easily reproduced by chemical synthesis. 
These fragments, called as bioactive peptides because they are necessary to perform 
biological activity, have many advantages over native proteins: they are stable, soluble, can 
be obtained by chemical synthesis with relatively low costs, moreover they ensure an 
extremely high level of purity and their biological activity does not depend on tertiary 
structure. Since the identification of the sequence Arg-Gly-Asp (RGD), as cell adhesion 
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mediator (that is present in many plasma proteins and extracellular matrix proteins, 
including fibronectin, vitronectin, collagen I, osteopontin and bone sialoprotein) a research 
field has been focused on the development of bioactive materials, obtained by deposition of 
synthetic peptides, containing the RGD sequence, on the biomaterials. The aim is to promote 
cell adhesion to the implants surfaces. Transmembrane receptors, belonging to the 
superfamily of integrins, are able to recognize the RGD sequence and to mediate cell 
adhesion; in particular, a high affinity of the RGD sequence for integrin ǂ5ǃ1 has been 
shown. Because of the importance of the affinity between integrins and adhesion proteins, 
and also because the same integrins are owned by many cell types, the problem of a non-
specific cell adhesion to RGD modified implant surface has been introduced (Puelo & Nanci, 
1999). Some research groups are trying to overcome this problem using synthetic peptides, 
with a particular conformation. The used peptides are longer than the short tetra, penta and 
hexapeptides (Rezania et al., 1997). Other groups are considering the use of no RGD 
peptides that may have greater specificity for bone cells. Nowadays, many studies are 
aimed to the development of surfaces functionalization with adhesion peptides; which are 
selective for osteoblastic cells. This approach take advantage of the characteristic mechanism 
of osteoblast adhesion based on the interaction between heparan sulfate proteoglycans, on 
the cell membrane, with heparin binding sites in the extracellular matrix proteins. Peptide 
mimicry studies concerning the amino acid sequences binding to heparin, made on several 
proteins (eg. human vitronectin, apolipoprotein E, B-100 and platelet factor IV), led to the 
identification of highly conserved signal sequences type XBBXBX XBBBXXBX (B is a basic 
amino acid and X is a non-basic amino acid) (Cardin & Weintraub, 1989). Subsequent 
studies have identified the minimal sequence for the osteoblast adhesion via heparan sulfate 
proteoglycans. The sequence proposed is the tetrapeptide Lys-Arg-Ser-Arg (KRSR), which 
replicates the motif BBXB. In addition, has been demonstrated that the osteoblastic cells 
interact with the RGD and KRSR peptides through two distinct types of molecules that are 
integrins and heparan sulfate proteoglycans. In fact, the interaction between the membrane 
integrins and the peptide RGD does not inhibit the interaction of osteoblastic cells with the 
peptide KRSR (Dee et al., 1998).  
A significant feature of the sequence KRSR seems to be its selective action on osteoblasts; 
indeed has been demonstrated a significant increase of bone cells adhesion on a support 
patterned with this sequence, instead there were no appreciable results for endothelial  and 
fibroblasts cells (Dettin et al., 2002).  
The mechanism of adhesion, mediated by integrin, is not specific to osteoblasts; in fact the 
sequences containing the RGD motif are able to promote the adhesion of several cell types 
(eg. Fibroblasts) as well as osteoblasts, instead mechanism of adhesion mediated by 
proteoglycans is specific for osteoblasts. Further investigations have been done to identify 
potential peptide sequences binding to membrane heparan sulfate proteoglycans by the 
motif XBBXBX and XBBBXBBX in vitronctin, fibronectin, sialoprotein, bone thrombospondin 
and osteopontin. This led to the identification of several peptides (HVP) contained in the 
sequence (339-364) of human vitronectin (Dettin et al., 2002). Also in this study has been 
shown that the new peptides identified are able to promote osteoblast adhesion via 
membrane proteoglycan. In particular, peptide sequence (351-359) has a higher activity than 
RGD peptides and fibronectin. Another approach is to use two different peptides on the 
same surface, one for the interaction with integrins and the other one for interaction with 
heparan sulfate proteoglycans. In this way, both mechanisms of osteoblasts adhesion are 
exploited and a better cell adhesion to the material should be reached (Rezania & Healy, 
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1999). The release of one or more of these factors, which have an important physiological 
role on osteogenesis at the bone-implant interface, promote the bone formation. 
2.1.2 Biomimicry to improve hydroxyapatite deposition 
The hydroxyapatite (HA) is considered the best osteoconductive material. It takes directly 
part in bone formation and in particular in the mineralization step, providing substances 
necessary to the tissue. It is widely used as coating for titanium and its alloys; it is applied 
by plasma spray technique. These coatings chemically modify the titanium surface, 
prompting a close interaction with the surrounding tissue mediated by chemical bonds 
(Davies, 2003; Brossa et al., 1993; Klein et al., 1991). The main problem with this approach is 
the coating long-term stability which may be subject to phenomena of delamination and 
hence loss of adhesion with the substrate (Kim, 1996). The excellent results obtained by the 
osteoconductive coatings in terms of osteoinegration capacity led to the study and the 
development of alternative methods of coating. An anodizing technique, known as Anodic 
Spark Deposition or Anodic Spark Discharge (ASD) has been considered, as a starting point 
for the development of treatments designed to improve osteointegration (Ishizawa, 1995a, 
1995b, 1997). With this technique it is possible to obtain porous surfaces rich in oxygen, with 
a relatively thick oxide layer, enriched with electrolytes dissolved in the medium during the 
anodic deposition process (Schreckenbach, 1999). The functionalized surfaces presented in 
this study were developed by a three steps ASD (Sandrini, 2003, 2005); in particular, this 
functionalization consists of two following steps of ASD that is made in solutions containing 
phosphate and calcium ions, followed by a step of alkaline attack. This biomimetic 
treatment is able to provide a thin titanium oxide layer, which is nanoporous and contain 
calcium and phosphorus (Zhu, 2001; Chiesa 2003). Further chemical treatments of surface 
modification have been used to enrich the surface with-OH groups, which act as preferential 
sites for precipitation of hydroxyapatite that is the main component of the bone mineral 
phase. It has been shown that these surfaces induce an enhanced primary osteointagration 
that leads to a reliable and durable implants osteointagration. 
3. Experimental procedure 
The biomimetic surfaces above described were tested to evaluate the osteogenic primary 
response and the osteointegration of implants through two separate experiments. In both 
trials the outbreed male New Zealand White rabbit was chosen as animal model. The 
rabbits, weighing 4.3 ± 0.2 kg, were at reproductive age and skeletal maturity, using as index 
the successful welding of the femoral growth metaphysis. European and Italian regulations 
on animal experimentation (Italian DL 27 January 1992 N°116 -European union 86/609 CEE) 
were strictly followed during the entire studies (Health Ministry Authorisation 21/01/2004; 
19/01/2007; 16/04/2010). As anatomical site for the implantation, the distal epiphysis of the 
femur was chosen. It is mainly characterized by spongy bone with a periosteal thin coating 
made up of compact bone tissue, the exception is for the articular edge that is covered of 
articular hyaline cartilage. Since that the surfaces to be tested are designed mainly for oral 
implantology, the anatomical site chosen for the in vivo trials presented a type of bone tissue 
similar to maxillary and mandibular bones. Surgical procedures were performed aseptically 
under general anesthesia (Domitor, Pfizer, New York, NY 0.1mL/kg; Ketavet 100, Gellini, 
Latina, Italy 0.3mL/kg; Isoflurane-Vet, Me´rial, Duluth, GA). In particular, after arthrotomy 
and dislocation, the trocheal grove was exposed and a precise hole was created, using a low 
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rotational drilling speed and continuous internal cooling, strictly parallel to the long axis of 
the femur (samples HVP(351-359) trials: 3.04 mm diameter and 14.08 mm length; samples 
ASD trials: 3.00 mm diameter and 13.00 mm length). Both the studies are designed on a 
bilateral approach. The soft tissues suture was done in separate layers using interrupted 
sutures. After surgery, the samples position was assessed by X-ray. All the materials tested 
in the studies described herein are subject to patents. 
Regarding the trials for the functionalization with the HVP peptide (351-359) nine rabbits 
were used; for each animal, one peptide-grafted cylinder (HVP) was inserted in the left 
femur, whereas one nongrafted cylinder (CTRL) in the right femur as internal control. On 
the basis of time points, rabbits were randomly divided into three groups: the first was 
sacrificed 4 days after surgery (4D group), the second 9 days after surgery (9D group), and 
the third 16 days after surgery (16D group). 
Regarding the trials for the ASD treatments, ASD1 and ASD2 surface treatments that 
involved two consecutive ASD processes carried out in different electrolyte solutions at 
different voltage ranges, and followed by an alkali etching processes were used. The first 
ASD was performed in a solution containing phosphate anions and calcium cations; the 
second ASD was performed in a solution containing only calcium cations. ASD 1 and ASD 2 
differ only for a final chemical treatment: ASD 1 was obtained in NaOH solution, instead 
ASD 2 was obtained by a final chemical treatment in KOH solution. An acid-etching 
treatment ETC was used as internal control. Eight implants for each surface (ETC, ASD 1, 
and ASD 2) were inserted into the left and right femoral epiphysis of the rabbits, avoiding 
implanting the same materials in the counterlateral; a total of 24 implants were placed. On 
the basis of time points, rabbits were randomly divided into two groups: the first was 
sacrificed 2 weeks after surgery (2W); the second 4 weeks after surgery (4W).  
To assess the new bone apposition and the osteointegration fluorochromic bone vital 
markers were used; these are fluorescent substances that allow to highlight areas where 
bone growth occurs during the administration period. Fluorochrome labels, when bound to 
calcium ions, can be incorporated at sites of mineralization in the form of hydroxyapatite 
crystals. As result, the fluorescent label demarcates the mineralization front at the time of 
administration and can be detected in histological sections without any further staining or 
decalcification (van Gaalen et al., 2010; Rahn, 2003). The florochromic bone markers used in 
these studies were: Calcein Green (CG, 5 mg/kg BW; Sigma), Calcein Blue (CB, 30 mg/kg 
BW; Sigma), Xylenol Orange (XO, 90 mg/kg BW; Sigma). These fluorochromes generate 
different color clearly distinguishable from each other (green, blue and red) and thus can be 
used sequentially, in order to highlight the bone neodeposition respectively to each marking 
period. For the HVP trials CG was administered for 2 days after surgery to all groups; XO 
was administered on the seventh and eighth day after surgery to the animals of the 9D 
group only; CB was administered on days from 9th to 15th after surgery, to the animals of 
the 16D group only. For the ASD trials CG was daily administered for the first week after 
surgery to all groups; CB was daily administered for the second week after surgery to all 
groups; AR was daily administered for the fourth week after surgery to 4W animals. At the 
end of the experimental trials, the implants and surrounding bone were immediately 
excised and excess tissue was removed. The implant containing tissue blocks were promptly 
fixed in paraformaldehyde 4%, dehydrated in alcoholic solutions of increasing concentration 
(70 up to 100%), treated with xylene, and finally embedded in polymethylmethacrylate 
resin. The histological and histomorphometrical analysis were performed by a motorized 
microscope (Nikon Eclipse 90i, Tokyo, Japan), equipped for polarized light and 
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fluorescence. Parameter calibrations for magnification and image acquisition were fixed on 
the basis of standardized conditions imposed before the histomorphometric. The following 
parameters were considered (Parfitt et al., 1987; Recker, 1983; Schnitzler & Mesquita, 2006): 
- Bone-to-implant contact (%) [Bc]: it was calculated as the ratio between the length of the 
bone profile in direct contact with the implant surface and the length of the implant 
profile. 
- Mineral apposition rate for single label (μm/day) [MAR-SL]: it was calculated as the 
ratio between the average thickness of the marking band and the duration of the 
administration period for each bone marker. 
- Mineralizing surface versus bone surface (%) [MS/BS]: it was calculated as the ratio 
between the surface marked with the vital marker (under fluorescence) and the whole 
bone surface within the area of interest (under polarized light). This parameter was 
measured for each vital marker administered.  
Histomorphometric data were statistically checked by means of one-way analysis of 
variance (ANOVA) and Tukey’s multiple comparison tests, with the statistical tool SPSS 
v.18.0. Data are reported as means ± standard deviations at a significance level of p<0.05. 
3.1 Results 
Observation of X-rays and histological sections has confirmed the correct positioning of the 
specimens in the anatomical sites, in fact they are centrally located in the distal femoral 
epiphysis, surrounded by trabecular bone. The Goldner’s trichrome stain excluded the 
interposition of fibrous connective tissue at the bone-implant for all the tested surfaces.  
With regard to trials for the functionalization with the HVP peptide (351-359) is detectable, 
through the polarized light analysis, already in 4D group, a thin trabeculation of newly 
formed bone closely associated with the implant surface, which thickens in the 9D group. In 
the newly formed bone numerous round shape osteocytes, characteristic of woven fiber 
bone, were detected. In agreement with these observations, at the experimental time of 4D, 
from the analysis of bone vital markers is noticeable an osteogenic activity at the interface 
that is confirmed by the polarized light analysis (Fig. 1). 
For each parameter considered the results of static and dynamic quantitative histology 
(Cacchioli et al., 2009) are detailed below in the text and plotted in the figure (Fig. 2). 
The bone-to-implant contact (Bc) shows an upward trend over time, from 4D to 16D, in both 
CTRL and HVP. This increase is statistically significant, both for CTRL and HVP going from 
4D to 9D (p <0.01), instead statistically significant only for HVP from 9D to 16D (p <0.01). The 
bone-to-implant contact is always higher for HVP implants with a statistical significance at 9D 
(p <0.05) and 16D (p <0.01). The increase that occurs in Bc from 4D to 9D, for both HVP and 
CTRL implants, indicates that this is the time interval at which a widest bone neodeposition 
occurred (Fig. 2). This observation is supported by data on the mineral apposition rate, 
because it showed a statistically significant (p <0.01) upward trend both for HVP and CTRL 
surfaces, from 4D to 9D, where it presented its peak. Then there is a statistically significant (p 
<0.01) decrease, both for CTRL and HVP surfaces  from  9D to 16D.  
HVP groups have to have a higher mineral apposition rate than the CTRL groups at all 
experimental times (4D, 9D and 16D) (Fig. 2). 
The Calcein Green - Mineralizing surface vs. Bone surface [CG-MS/BS] was measured in all 
groups HVP and CTRL at the end of each experimental time. Since the CG marker was 
administered within two days after the surgery in all experimental groups, and measured 
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Fig. 1. Histological results of HVP (351-359) trials. (a-b) Goldner’s trichrome stain (original 
magnification, 40x). Primary new bone directly apposed to the interface. (a) The picture 
corresponds to an HVP samples belonging to the 9D group; (b) the picture corresponds to 
an HVP samples belonging to  the 16D group. Arrows show newly formed bone 
characterized by round shape osteocytes. (c) Polarized light microscopy with compensation 
plate (original magnification, 40x). Woven fiber bone located at the interface in the HVP 
sample, belonging to 16D group. Arrows indicate the woven fiber bone. (d) Fluorescent 
microscopy of CG and CB fluorochromic bone marker (original magnification, 20x). The 
picture represents the direct bone apposition to the interface the days immediately after 
surgery (Calcein green bone marker) and the following bone apposition, marked with 
Calcein Blue in the HVP sample  belonging to 16D groups. 
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Fig. 2. Static and dynamic histomorfometric results of HVP (351-359). 
after 4D, 9D and 16D, respectively, its evaluation, relatively to the 9D and 16D groups, is an 
indirect index of the bone remodeling activity occurred from CG administration until 
animal sacrifice. For the 4D group, data showed, a statistically significant difference (p 
<0.01) between CTRL and HVP. For both the 9D and 16D groups, data collected showed the 
tendency of groups HVP to present higher values compared to CTRL, although these 
differences are not statistically significant as it is highlighted at 4D. This could be interpreted 
as result of the remodeling activity occurred nearby at the interface. The Xylenol Orange - 
Mineralizing surface vs. Bone surface [CG-MS/BS] was measured for the 9D group, since 
the XO marker was administered to this group only. The comparison between CTRLs and 
HVPs average values did not show any significant difference. The Calcein Blue - 
Mineralizing surface vs. Bone surface [CG-MS/BS] was measured for the 16D group, since 
the CB marker was administered to this group only. The comparison of averages shows, 
even if not supported by statistical significance, a higher values trend of the HVP than the 
respective CTRL surfaces (Fig. 2). 
With regard to trials for the treatment with ASD, for the 2 weeks group newly grown bone 
tissue in direct contact with the sample surface was already clearly visible at this time point. 
In polarized light microscopy this newly formed bone tissue has the morphology of primary 
woven bone, that is the first tissue to fill quickly and evenly the gap between the bone and 
the implant. This is an important support to ensure the implant stability and consequently 
allow an earlier loading of the implant. For the 4 weeks group the remodeling activity on the 
newly formed bone tissue was detectable, in fact it is observed an increase in the thickness 
of trabecular woven bone and at the same time, portions of bone with parallel fiber 
organization structured as secondary bone were present (Fig. 3). 
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Fig. 3. Histological results of ASD trials. (a-b) Goldner’s trichrome stain (original 
magnification, 40x). Primary new bone directly apposed to the interface. (a) The picture 
corresponds to an ASD samples belonging to the 2W; (b) the picture corresponds to an ASD 
samples belonging to  the 4W group. Arrows show newly formed bone in (a) and the result 
of remodeling activity in (b). (c) Polarized light microscopy with compensation plate 
(original magnification, 40x). Woven fiber bone and parallel fiber bone located at the 
interface in the ASD sample, belonging to 4W group. Arrow indicates the woven fiber bone. 
(d) Fluorescent microscopy of CG and XO fluorochromic bone marker (original 
magnification, 20x). The picture represents the direct bone apposition to the interface the 
days immediately after surgery (Calcein green bone marker) and the following bone 
apposition, marked with Xylenol Orange in the ASD sample belonging to 2W group. 
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For each parameter considered the Results of static and dynamic quantitative histology 
(Ravanetti et al., 2010) are detailed below in the text and plotted in the figure (Fig. 4). 
 
 
Fig. 4. Static and dynamic histomorfometric results of ASD trials. 
The bone to implant contact, in the 2Wgroup, shows the achievement of a greater contact for 
the surface ASD2 as compared to ETC (ASD 2 vs. ETC p <0.01). The ASD1 surface has 
slightly higher contact  than the ETC, but this is not statistically significant. 
For the 4W group, all the tested surfaces achieved a similar bone to implant contact, without 
statistical significance. From 2W to 4W, for both the ASD surfaces, no significant increase 
resulted, while a significant increase is detected for the ETC surface (2W ETC vs. 4W ETC p 
<0.01). The mineral apposition rate concerning the first week after surgery, indicating a 
higher bone deposition rate in both ASD surfaces as compared to ETC surface (ASD1 vs. 
ETC p <0.01; ASD2 vs. ETC p <0.05) (Fig. 4). The mineral apposition rate concerning the 
fourth week after surgery indicates a decrease in mineral apposition rate for the ASD 2 and 
ASD 1 surfaces, while for the ETC surface the rate detected at 2W was maintained. Despite 
these changes, the mineral apposition rate on the fourth week has maintained the same 
trend of the first week, in fact the surfaces ASD 1 and ASD 2 resulted higher than ETC, but 
without statistical significance (Fig. 4). 
The Calcein Green - Mineralizing surface vs. Bone surface [CG-MS/BS] was measured in 
both experimental times 2W and 4W, since the Calcein Green was administered the first 
week after surgery to all experimental groups. For the 2W group, the bone activity for ETC 
samples appears to be slightly lower than for ASD 1 and ASD 2 samples, but no statistically 
significant difference were detected. For the 4W group, a significant decrease in absolute 
value and a similar situation among surfaces was observed; this decrease is due to 
remodeling activity and it was statistically significant only for ASD1 and ASD2 surfaces 
going from the experimental time 2W to 4W (2W ASD1 vs. 4W ASD1 p <0.01; 2W ASD 2 vs. 
4W ASD2 p <0.01). 
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The Calcein Blue - Mineralizing surface vs. Bone surface [CB-MS/BS] was measured in both 
experimental times 2W and 4W, since the Calcein Blue was administered the second week 
after surgery in all experimental groups. For the 2W group, no statistically significant 
differences among materials were came out. For the 4W group, as noted also for the Calcein 
Green marker, a strong decrease in absolute value for the surfaces ETC and ASD1 carried 
out (2W ETC vs. 4W ETC p<0.01; 2W ASD1 vs. 4W ASD1 p<0.01), however a similar 
situation among surfaces was maintained (Fig. 4). 
4. Conclusion 
The goal of current implantology on osseointegrated implants aims to design bioactive and 
biomimetic materials enabling to monitor, pilot and speed up the processes involved in the 
osteointegration, make possible a more rapid healing. Such strategies were widely 
considered highly encouraging factors for the development of a better clinical development 
of an endosseous implant. 
The most common cell-binding domain which has beeen used extensively as a candidate 
peptide to enhance cell adhesion onto biomaterial surface is the RGD-sequence. The 
exploitation of the RGD sequence for improving cell adhesion has been known since the 
1980s; many studies confirmed its suitability as bioactive adhesion peptide (Ruoslahti, 2003) 
Other non-RGD-containing cell binding domain exist, such as tyrosine-isoleucine-glycine-
serine-arginine (-YIGSR-) and isoleucine-lysine-valine-alanine-valine- (IKVAV) in laminin, 
arginine-glutamate-aspartate-arginine-valine (-REDRV) and leucine-aspartic acid-valine 
(LDV) in fibronectin aspartate-glycine-glutamate-alanine (DGEA) in collagen I, and various 
heparin binding domains (Rezania & Healy1999). 
Regarding the first study here presented, a higher mineral apposition rate, concomitant with 
an increase activation in terms of osteogenic surface for the experimental times 4 and 9 days 
in the HVP functionalized group has contributed to achieved an higer bone-implant contact 
observed at the experimental times of 9 and 16 days. The surface functionalized with HVP 
peptide (351-359), improves the osteogenic response in a short time after implant 
positioning, and therefore stimulates the acceleration of the new bone deposition at the 
interface. So we can assume a more massive osteoblastic adhesion to the implant surface 
that produces these effects directly on the interface. Published data indicates that the 
osteogenic activity of RGD-grafted implants, measured by bone-contact histomorphometric 
analysis, achieved its highest values within 2 weeks after surgery in mini pigs. In a further 
in vivo study on rabbits, more than 50% of bone defects are covered using the RGD 
sequence within 2 weeks. The effects due to components of extracellular matrix (e.g., 
collagen type I, RGD sequence, and chondroitin sulfate) used for coating titanium implants 
have been checked in rats, from 4 up to 28 days after surgery. This early stimulation of 
osteogenic activity improves primary fixation of the implant and, consequently, should lead 
to a faster osseointegration with the clinical benefits derived. 
Different physical treatments of titanium can improve osteointegration through a better 
mechanical interface but not provide a chemical interaction with bone. To produce a 
bioactive titanium, biomaterials research has focused on osteoconductive materials, such as 
hydroxyapatite coatings. The poor long-term performance of plasma-sprayed HA coatings 
stimulated research for the study of alternative deposition methods of HA coatings 
(Forsgren et al., 2007) and for the development of new approaches based on the nanoscale 
modification of the material surface. Among the electrochemical methods, an attractive 
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technique that can be applied to titanium and titanium alloys to obtain a biomimetic thin 
and porous surface layer enriched in calcium and phosphate is known as anodic spark 
deposition (ASD). 
Regarding the second study, the biomimetic electrochemical treatments, ASD1 and ASD2, 
supports the establishment of a greater bone-implant contact after two weeks by 
implementing primary osteogenic response in vivo. This is not so obvious to the 
experimental time of four weeks, as the osteogenic response of the control surface ETC is 
delayed with respect to biomimetic surfaces. All the three tested materials were found to be 
suitable for their use as prosthetic endosseous implants; however, the ASD biomimetic 
treatments have shown some benefits in terms of acceleration in the biological response. 
In these studies promising results were obtained encouraging to continue deepen the study 
of these surfaces for the possible development of clinically exploitable endosseous devices. 
In fact, both the tested biomimetic promoted the primary osseointegration compared to the 
control surfaces, in short experimental times after implantation. 
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